CoChat

Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics

Gerweck, Leo E., Vijayappa, Shashirekha, Kozin, Sergey · 2006 · Molecular Cancer Therapeutics

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

The extracellular pH of tumor tissue is significantly lower than the extracellular pH of normal tissue, whereas the intracellular pH of both tissues is similar. In principle, extracellular acidity may be expected to enhance the intracellular uptake and cytotoxicity of weak acid chemotherapeutics that are membrane permeable in their uncharged state and inhibit the efficacy of weak bases. However, procedures for assessing the role of the gradient as a determinant of drug efficacy in vivo by altering the pH gradient may also alter drug availability and thus mask or exaggerate the effect of the gradient change. In the present study, we have altered the extracellular pH of tumors and compared the effect of the resultant pH gradient change on the efficacy of a weak acid versus a weak base. This experimental design gives rise to a change in the ratio of chlorambucil- to doxorubicin-induced tumor growth delay, independent of possible changes in drug availability. The extracellular pH of the 54A human tumor in NCr/Sed/nu/nu mice was altered by administration of 5 mg/g i.v. glucose. The resultant 0.2 pH unit increase in the tumor cell pH gradient gives rise to a predicted 2.3-fold increase in the ratio of chlorambucil to doxorubicin growth delay. The experimentally measured change in the growth delay ratio was 2.1. The results provide compelling evidence that the pH gradient in a determinant of the efficacy of weak electrolytes in the complex in vivo environment and may be exploited for the treatment of cancer.

Overview

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-06-0024

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Cited by

See all 375

Metadata

Authors
Gerweck, L. E., Vijayappa, S., & Kozin, S.
Affiliations
Massachusetts General Hospital (US)
Venue
Molecular Cancer Therapeutics
Published
2006-05-01
Volume
5
Issue
5
Pages
1275-1279
ISSN
  • 1535-7163 (ISSN-L)
  • 1538-8514
OpenAlex
W2148812205
Cited by
362
References
38
Citations by year
2026: 2 · 2025: 19 · 2024: 14 · 2023: 14 · 2022: 30 · 2021: 28 · 2020: 20 · 2019: 18 · 2018: 17 · 2017: 26 · 2016: 12 · 2015: 18 · 2014: 24 · 2013: 24 · 2012: 17
FWCI
4.65
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Cancer Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA092366)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
tumor extracellular pH, pH gradient, chlorambucil, doxorubicin, tumor growth inhibition, glucose administration, intracellular pH, drug efficacy
MeSH terms
Animals, Antineoplastic Agents, Chlorambucil, Doxorubicin, Extracellular Space, Glucose, Humans, Hydrogen-Ion Concentration, Male, Mice, Inbred Strains, Neoplasm Transplantation, Neoplasms, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. https://app.cochat.ai/papers/10.1158/1535-7163.mct-06-0024
The paper
Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006). Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-06-0024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.